山东药玻：公司预灌封注射器项目设备已全部到位，预计年底能完成调试

Group 1 - The core viewpoint of the article is that Shandong Pharmaceutical Glass (600529) is currently undergoing a restructuring process involving its controlling shareholder, and the company is only disclosing relevant progress without having received any formal notifications [1] - The company has completed the installation of equipment for its pre-filled syringe project, with expectations to finish debugging by the end of the year [1]